Journal of Virology, January 2001, p. 215-225, Vol. 75, No. 1
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.1.215-225.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
B and Myc Proteins in Apoptosis
Induced by Hepatitis B Virus HBx Protein

Department of Microbiology, New York University School of Medicine, New York, New York 10016
Received 31 May 2000/Accepted 29 September 2000
Chronic infection with hepatitis B virus (HBV) promotes a high
level of liver disease and cancer in humans. The HBV HBx gene encodes a
small regulatory protein that is essential for viral replication and is
suspected to play a role in viral pathogenesis. HBx stimulates
cytoplasmic signal transduction pathways, moderately stimulates a
number of transcription factors, including several nuclear factors, and
in certain settings sensitizes cells to apoptosis by proapoptotic
stimuli, including tumor necrosis factor alpha (TNF-
) and etopocide.
Paradoxically, HBx activates members of the NF-
B transcription
factor family, some of which are antiapoptotic in function. HBx induces
expression of Myc protein family members in certain settings, and Myc
can sensitize cells to killing by TNF-
. We therefore examined the
roles of NF-
B, c-Myc, and TNF-
in apoptotic killing of cells by
HBx. RelA/NF-
B is shown to be induced by HBx and to suppress
HBx-mediated apoptosis. HBx also induces c-Rel/NF-
B, which can
promote apoptotic cell death in some contexts or block it in others.
Induction of c-Rel by HBx was found to inhibit its ability to directly
mediate apoptotic killing of cells. Thus, HBx induction of NF-
B
family members masks its ability to directly mediate apoptosis, whereas
ablation of NF-
B reveals it. Investigation of the role of Myc
protein demonstrates that overexpression of Myc is essential for acute sensitization of cells to killing by HBx plus TNF-
. This study therefore defines a specific set of parameters which must be met for
HBx to possibly contribute to HBV pathogenesis.
Present address: Rockefeller University, New York, NY 10012.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|